Sandbox Reserved 1703: Difference between revisions
No edit summary |
No edit summary |
||
Line 38: | Line 38: | ||
==Clinical Relevance== | ==Clinical Relevance== | ||
[https://en.wikipedia.org/wiki/Metabotropic_glutamate_receptor mGluRs]occur both presynaptically and postsynaptically in the Central Nervous System | [https://en.wikipedia.org/wiki/Metabotropic_glutamate_receptor mGluRs]occur both presynaptically and postsynaptically in the Central Nervous System <ref name="Wiki">“Metabotropic Glutamate Receptor.” Wikipedia, Wikimedia Foundation, 27 Mar. 2022, https://en.wikipedia.org/wiki/Metabotropic_glutamate_receptor</ref>. mGluRs play a variety of roles, such as in disease, [https://en.wikipedia.org/wiki/Synaptic_plasticity synaptic plasticity], and modulation of other receptors<ref name="Wiki"/>. Manipulation of these receptors are starting to be used as drug targets for [https://en.wikipedia.org/wiki/Parkinson%27s_disease Parkinson's Disease], [https://en.wikipedia.org/wiki/Fragile_X_syndrome Fragile X Syndrome], and Schizophrenia. | ||
====Schizophrenia==== | ====Schizophrenia==== |